شماره تماس 09371686566   
لطفا جهت خرید کتب چاپی استعلام قیمت جدید بگیرید
وارد شوید
x
یا
x
ثبت
x

یا

دانلود کتاب Petz & Garratty's Immune Hemolytic Anemias, 3rd Edition (ORIGINAL PDF)

5,000,000 تومان
2,700,000 تومان
46 % تخفیف
کد : 5635
انتخاب ها:


نام کتاب: Petz & Garratty's Immune Hemolytic Anemias, 3rd Edition


نويسنده/نويسندگان: Authors: Waseem Anani,Gregory Denomme

James T. Goodrich,
Robert F. Keating


نوع فايل: PDF ORIGINAL
سال انتشار: 2027
تعداد صفحات : 608
ناشر : Thieme/AANS

شابک :9781626231078


نسخه چاپی تمام رنگی ، با کیفیت بالا ،جلد هارد

*بهترین کیفیت افست را از ما بخواهید*

شماره تماس ، واتس آپ و تلگرام 📞 09371686566📞

To buy in dollars, if you have PayPal, send a message to our Telegram
+989371686566

شماره تماس ، واتس آپ و تلگرام 📞 09371686566📞

🌸🌸🌸 🌸🌸🌸 🌸🌸🌸 🌸🌸🌸 🌸🌸🌸🌸

.

 

Date of Publication: 09/2026
Synthesizing the expertise of the world’s most respected authorities on these challenging conditions, Petz & Garratty's Immune Hemolytic Anemias, 3rd Edition, offers up-to-date, comprehensive coverage for today’s clinical hematologists, pathologists, transfusion medicine fellows, residents, and laboratory healthcare professionals. This extensively revised text examines the selection and interpretation of laboratory tests as well as all of today's best diagnostic and treatment methods for the full range of immune hemolytic anemias. Continuing the tradition of excellence begun by Drs. Lawrence D. Petz and George Garratty, this fully revised edition, now meticulously updated and edited by Drs. Waseem Anani and Gregory Denomme, remains the foremost resource on immune hemolytic anemias.
 
Synthesizing the expertise of the world’s most respected authorities on these challenging conditions, Petz & Garratty's Immune Hemolytic Anemias, 3rd Edition, offers up-to-date, comprehensive coverage for today’s clinical hematologists, pathologists, transfusion medicine fellows, residents, and laboratory healthcare professionals. This extensively revised text examines the selection and interpretation of laboratory tests as well as all of today's best diagnostic and treatment methods for the full range of immune hemolytic anemias. Continuing the tradition of excellence begun by Drs. Lawrence D. Petz and George Garratty, this fully revised edition, now meticulously updated and edited by Drs. Waseem Anani and Gregory Denomme, remains the foremost resource on immune hemolytic anemias.

Key Features
  • Provides critical information to help hematologists and other clinicians become more familiar with diagnosis and treatment of immune hemolytic anemias, and develop the rapid, informed decision-making skills that these conditions often demand
  • Includes both foundational knowledge and clinical guidance for diagnosis
  • Highlights laboratory features of individual disease states and provides guidance on tests used to determine differential diagnoses
  • Provides recommendations for navigating difficult cases where diagnostic testing and/or clinical presentation are unclear
  • Covers key topics including drug-induced hemolytic anemia, suppressed erythropoiesis in HDFN, blood transfusion in autoimmune hemolytic anemias, transplantation and autoimmune hemolytic anemias, with two new chapters on monoclonocal antibody therapies affecting red blood cells, and pediatric immune hemolytic anemia
  • An eBook version is included with purchase. The eBook allows you to access all of the text, figures, and references, with the ability to search, make notes and highlights, and have content read aloud. Additional digital ancillary content may publish after the publication date

Author Information
Waseem Anani,Medical Director: Immunohematology Reference Laboratory and Blood Services, Associate Professor (Clinical), University of Utah School of Medicine, USA;Gregory Denomme,Grifols Laboratory Solutions, Western University, London, Canada
 
ISBN Number 9780443224270
Author Information Waseem Anani,Gregory Denomme
Copyright Year 2027
Edition Number 3
Format Book
Format Size 8 x 10 mm
Imprint Elsevier
Page Count 608
Publication Date 24-09-2026
Stock Status IN STOCK